AAAAAA
Results:
1-13
|
Results: 13
Authors:
Tan, ACITL
Brouwer, JT
Glue, P
van Leusen, R
Kauffmann, RH
Schalm, SW
de Vries, RA
Vroom, B
Citation: Acitl. Tan et al., Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study, NEPH DIAL T, 16(1), 2001, pp. 193-195
Authors:
Jen, JF
Glue, P
Ezzet, F
Chung, C
Gupta, SK
Jacobs, S
Hajian, G
Citation: Jf. Jen et al., Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C, CLIN PHARM, 69(6), 2001, pp. 407-421
Authors:
Glue, P
Schenker, S
Gupta, S
Clement, RP
Zambas, D
Salfi, M
Citation: P. Glue et al., The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease, BR J CL PH, 49(5), 2000, pp. 417-421
Authors:
Glue, P
Rouzier-Panis, R
Raffanel, C
Sabo, R
Gupta, SK
Salfi, M
Jacobs, S
Clement, RP
Citation: P. Glue et al., A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C, HEPATOLOGY, 32(3), 2000, pp. 647-653
Authors:
Jen, JF
Glue, P
Gupta, S
Zambas, D
Hajian, G
Citation: Jf. Jen et al., Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C, THER DRUG M, 22(5), 2000, pp. 555-565
Authors:
Glue, P
Fang, JWS
Rouzier-Panis, R
Raffanel, C
Sabo, R
Gupta, SK
Salfi, M
Jacobs, S
Citation: P. Glue et al., Pegylated interferon-alpha 2b: Pharmacokinetics, pharmacodynamics, safety,and preliminary efficacy data, CLIN PHARM, 68(5), 2000, pp. 556-567
Authors:
Glue, P
Citation: P. Glue, The clinical pharmacology of ribavirin, SEM LIV DIS, 19, 1999, pp. 17-24
Authors:
Glue, P
Clement, RP
Citation: P. Glue et Rp. Clement, Cytochrome P450 enzymes and drug metabolism - Basic concepts and methods of assessment, CELL MOL N, 19(3), 1999, pp. 309-323
Authors:
Nyberg, L
Albrecht, J
Glue, P
Gianelli, G
Zambas, D
Elliot, M
Conrad, A
McHutchison, J
Citation: L. Nyberg et al., Changes in serum hepatitis C virus RNA in interferon nonresponders retreated with interferon plus ribavirin - A preliminary report, J CLIN GAST, 28(4), 1999, pp. 313-316
Authors:
Preston, SL
Drusano, GL
Glue, P
Nash, J
Gupta, SK
McNamara, P
Citation: Sl. Preston et al., Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology, ANTIM AG CH, 43(10), 1999, pp. 2451-2456
Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics
Authors:
Glue, P
Andersen, KO
Hansen, MA
Stage, KB
Hansen, H
Norrie, B
Hansen, PEB
Knudsen, L
Thomsen, R
Pedersen, I
Jessen, IM
Haffner, F
Hansen, JB
Berthou, E
Kierkegaard, H
Andersen, TH
Bjarking, L
Bech, P
Bendsen, BB
Spanager, S
LaBianca, J
Jha, S
Hoybye, E
Bysted, M
Rasmussen, NA
Moller, AG
Welter, H
Justesen, EM
Merinder, L
Andersen, F
Bartels, U
Borg, L
Christensen, J
Weeke, A
Raben, H
Larsen, JK
Knudsen, H
Jorgensen, O
Knudsen, AF
Horsboll, H
Waago, K
Christensen, B
Christensen, NB
Thiesen, S
Wernlund, HH
Thomsen, IS
Christensen, EM
Skovgaard, K
Andersen, J
Andersen, M
Gram, LF
Brosen, K
Sindrup, SH
Fugmann, S
de Lasson, AR
Andersen, D
Gram, LF
Kragh-Sorensen, P
Bech, P
Bolwig, TG
Vestergaard, P
Larsen, JK
Citation: P. Glue et al., Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics, CLIN PHARM, 66(2), 1999, pp. 152-165
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
Authors:
Romach, MK
Glue, P
Kampman, K
Kaplan, HL
Somer, GR
Poole, S
Clarke, L
Coffin, V
Cornish, J
O'Brien, CP
Sellers, EM
Citation: Mk. Romach et al., Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166), ARCH G PSYC, 56(12), 1999, pp. 1101-1106
Authors:
Khakoo, S
Glue, P
Grellier, L
Wells, B
Bell, A
Dash, C
Murray-Lyon, I
Lypnyj, D
Flannery, B
Walters, K
Dusheiko, GM
Citation: S. Khakoo et al., Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions, BR J CL PH, 46(6), 1998, pp. 563-570
Risultati:
1-13
|